Altered gut microbiota in Parkinson's disease patients with motor complications

Kai Takahashi1, Hiroshi Nishiwaki2, Mikako Ito2

  • 1Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan.

Abstract

Insights

Gut dysbiosis is linked to Parkinson's disease (PD) motor complications. Specific bacteria changes, Lachnospiraceae Blautia and Lactobacillus, were associated with wearing-off and dyskinesia in PD patients.

Area of Science:

  • Microbiology
  • Neuroscience
  • Gastroenterology

Background:

  • Parkinson's disease (PD) is increasingly recognized to have connections with gut microbiota alterations, a condition known as gut dysbiosis.
  • However, the direct causal link between gut dysbiosis and the emergence of motor complications in PD remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between gut microbiota composition and the presence of motor complications, specifically wearing-off and dyskinesia, in patients with Parkinson's disease.
  • To identify specific bacterial genera or species that are significantly altered in PD patients experiencing motor fluctuations.

Main Methods:

  • 16S ribosomal RNA gene sequencing was employed to analyze the gut microbiota composition of 223 Parkinson's disease patients from four Japanese movement disorder centers.
  • Statistical analyses, including Analysis of Covariance (ANCOVA) adjusted for confounding factors, were used to assess the association between gut microbial relative abundance and clinical characteristics like wearing-off and dyskinesia.

Main Results:

  • Significant alterations in gut microbiota were observed in PD patients with motor complications.
  • Specifically, patients experiencing wearing-off showed a decreased relative abundance of Lachnospiraceae Blautia and an increased relative abundance of Lactobacillaceae Lactobacillus.
  • While dyskinesia was also noted, significant changes in gut microbiota were not consistently observed for this complication after correction. Age, disease duration, and wearing-off were identified as independent risk factors for altered Lachnospiraceae Blautia and Lactobacillus abundance.

Conclusions:

  • An altered gut microbiota composition, characterized by decreased Lachnospiraceae Blautia and increased Lactobacillaceae Lactobacillus, is significantly associated with motor complications in advanced Parkinson's disease.
  • These findings suggest that gut dysbiosis may play a role in the development or progression of motor fluctuations in PD, highlighting potential therapeutic targets within the gut microbiome.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
435
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
810
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
449